Videos

#welivescience Interview with Dr. Kerry Gilmore (Jul 24, 2020)
In this interview Gilmore talks about his innovative research approach, international cooperation on site and new solutions to enable a broad application of his research results. Learn more about his professional and personal experiences at Potsdam Science Park. more
Launch of the Max Planck-NTU Joint Laboratory for Artificial Senses (<span class="date style-scope ytd-video-secondary-info-renderer">14.01.2019)</span>
#NTUsg's new joint lab with Germany's Max Planck Institute of Colloids and Interfaces will research on and develop #robotics and #healthcare solutions. more
KLAS workshop: Opinions and reflections (Feb 19, 2018)
Knowledge Link through Art and Science workshop took place at the Max Planck Institute of Colloids and Interfaces in November 2017. We selected some short interviews of various participants for you to get a glimpse of what is all this about. more
Synthetic sugars for novel vaccines (22.6.2017)
Synthetic sugars are components of novel vaccines against infectious diseases such as multiresistant hospital microbes. A method for synthesizing sugars quickly and reliably was the brainchild of Peter H. Seeberger, Director at the Max Planck Institute of Colloids and Interfaces in Potsdam.
How Does the Interaction of Water with Collagen Lead to Pretension in Our Connective Tissues? (29. Mai 2017)
The connective tissues in our body – such as skin, tendon, or bones – all contain a molecule called collagen. When you cut your skin, it springs open. This shows that the tissues in our body are under pretension. The research presented in this video is interested in the question of whether the interaction of collagen with water causes this tension. more
How Can Vaccine Design Be Modified by the Use of Synthetic Sugars? (23. Mai 2017)
Streptococcus pneumoniae kills millions of people worldwide. For the subgroup serotype 8, prevalent in the United States and Western Europe, there is no vaccine to date. In this video, PETER H. SEEBERGER explains the approach of his research group to create a synthetic sugar vaccine against this bacterial infection that works in mice.
"Perspectives in Interface Research" (26.01.2017)
A new special issue in "Advanced Materials Interfaces" is dedicated to the 25th Anniversary of the Max Planck Institute of Colloids and Interfaces (MPI-CI) and highlights the Perspectives in Interface Research more
Biomaterials - patent solutions from nature (03.01.2017)
Animals and plants can produce amazing materials such as spider webs, wood or bone using only a few raw materials available. How do they achieve this? And what can engineers learn from them?
Kerry Gilmore - Breaking the Wall of Affordable Medicine, @Falling Walls Lab 2014 (Jan 22, 2015)
Assembly-line production of pure medicines in shipping containers will allow for the poor to produce. more
Peter H. Seeberger and Andreas Seidel-Morgenstern - the winner's of the 2015 Humanity In Science Award. [more]
BERLIN.MINDS is a community of leaders in science, the arts and business. It meets once a year for a closed-door flagship conference and several times for smaller conferences. [more]
On the occasion of the 10th anniversary of the Berlin declaration, Berlin High Schoolers and students meet Jack Andraka, a 16-year-old inventor and Open Access advocate. Together with Nick Shockey, Right to Research Coalition, and Daniel Kolarich, group leader at the Max Planck Institute of Colloids and Interfaces they speak about the necessity of Open Access in science and explain how it will enable everyone to be a scientist. [more]
Talk between Nick Shockey (Right to Research Coalition) and Daniel Kolarich (Max Planck Institute of Colloids and Interfaces) about OPEN ACCESS in the Science Gallery on 19.11.2013. [more]
Carbohydrates are not merely a source of our nutrition. Many sugars are bioactive in that their structure contains molecular information that is recognized by cell receptors to control various important biological functions, such as cell signaling and immune response. Therefore, the synthesis of complex sugars containing the “right” information and understanding their biomolecular interactions is crucial to the advances in biomedicine and related areas. [more]
As a schoolboy, Daniel Varon Silva was already creating shampoos and hand cremes. Chemistry was his favorite subject. Today the 35-year-old Columbian works at the Max Planck Institute of Colloids and Interfaces.His goal is to produce molecules tailor-made to have long-lasting, targeted effects in the body to combat diseases like multiple sclerosis, malaria, and tuberculosis. [more]
Researchers at the Max Planck Institute of Colloids and Interfaces have developed a process enabling the direct production of coal from biomass. Markus Antonietti and his group successfully managed to develop a method originally intended to produce carbon nano-particles so that it could be used for commercial coal production. Such coal could be used for heating purposes and might be used for electricity or even gasoline production. The 70 million tonnes of biomass that Germany produces every year would be sufficient to cover much of the country's energy needs.
[more]
Combining synthetic organic chemistry and immunology, Peter H. Seeberger examines the biochemical basis to identify sugars to accelerate the development of inexpensive vaccines. Seeberger, who, after many years as a professor of Chemistry at the Massachusetts Institute for Technology (MIT) and at the Eidgenössische Technische Hochschule Zürich (ETH), recently became director at the Max Planck Institute of Colloids and Interfaces in Potsdam and professor at Freie Universität Berlin. [more]
Peter Fratzl,a physicist at the Max Planck Institute of Colloids and Interfaces in Potsdam,is looking at what contributions the Euplectella aspergillum,a deep sea sponge known as the Venus Flower Basket,can make in the process of building skyscrapers. [more]
Go to Editor View